Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.
暂无分享,去创建一个
Anna L. Blobaum | D. Sheffler | C. Lindsley | Hyekyung P. Cho | P. Conn | C. Niswender | R. Morrison | Tristano Pancani | Anna L Blobaum | M. Turlington | M. T. Klein | T. Bridges | J. Daniels | Z. Xiang | J. Tarr | T. Utley | M. Wood | Paul R. Reid | R. Klar | T. Pancani